REQUEST A DEMO
Total
USD $0.00
Search more companies

Bon Natural Life Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bon Natural Life Ltd. Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The Company through its wholly-owned subsidiaries, is engaged in the research and development, manufacturing and sales of functional active ingredients extracted from natural herb plants which are widely used by manufacturer customers in the functional food, personal care, cosmetic and pharmaceutical industries. The Company sells its products to customers located in both Chinese and international markets.
The Company's products have similar economic characteristics with respect to raw materials, vendors, marketing and promotions, customers and methods of distribution. The Company's chief operating decision maker has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company, rather than by product types or geographic area; hence the Company has only one reporting segment.
HISTORY
2019 The Company was incorporated as an exempted company with limited liability under the laws of the Cayman Islands on December 11, 2019. The Company owns 100 equity interest of Tea Essence Limited, an entity incorporated on January 9, 2020 in accordance with the laws and regulations in Hong Kong.
2021
On July 6, 2021, the Company entered into a consulting agreement with a New York based consulting firm (“the consulting firm”), pursuant to which, the consulting firm will help the Company to (i) identify appropriate business partner candidates in New York or California in order to jointly establish a research and development center in the United States for future new product development; (ii) find opportunities to establish business relationship with U.S based companies with OEM demand and utilize the Company's manufacturing strength and capability to manufacture healthcare ingredient products for U.S companies under the OEM arrangement and (iii) help the Company to purchase or lease appropriate commercial facilities in the U.S...
The Company's ordinary shares started to trade on the Nasdaq Capital Market under the ticker symbol “BON” since June 24, 2021.
2022 As of September 30, 2022, the consulting firm has delivered a potential acquisition target to the Company, which is a small R D firm developing anti-aging formulas.

Headquarters
C601, Gazelle Valley No.69 Jinye Road, Xi'An Hi-Tech Zone, People'S Republic Of China
Xi'an; Shaanxi;

Contact Details: Purchase the Bon Natural Life Ltd. report to view the information.

Website: http://www.bnlus.com

Basic Information
Total Employees:
Purchase the Bon Natural Life Ltd. report to view the information.
Outstanding Shares:
Purchase the Bon Natural Life Ltd. report to view the information.
Financial Auditors:
Purchase the Bon Natural Life Ltd. report to view the information.
Incorporation Date:
2019
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
12.22%
Purchase this report to view the information.
5.174%
Purchase this report to view the information.
0.98%
Purchase this report to view the information.
0.22%
Purchase this report to view the information.
0.14%
Subsidiaries
Shaanxi App-Chem Health Industry Co., Ltd
Company Performance
Financial values in the chart are available after Bon Natural Life Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-28.03%
Total operating revenue
-28.03%
Operating profit (EBIT)
-92.93%
EBITDA
-76.41%
Net Profit (Loss) for the Period
N/A
Total assets
6.09%
Total equity
5.12%
Operating Profit Margin (ROS)
-17.68%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
3.75%
Quick Ratio
0.36%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?